Phase I/II study of adoptive T-cell therapy following in vivo priming with a HER2/neu vaccine in patients with advanced-stage HER2+ breast cancer.
Mary L. Disis
No relevant relationships to disclose
Andrew L Coveler
No relevant relationships to disclose
Doreen Higgins
No relevant relationships to disclose
Leonard A D'Amico
No relevant relationships to disclose
Chihiro Morishima
No relevant relationships to disclose
James Ross Waisman
No relevant relationships to disclose
Jessica Reichow
No relevant relationships to disclose
Jennifer Childs
No relevant relationships to disclose
Yushe Dang
No relevant relationships to disclose
Lupe G. Salazar
No relevant relationships to disclose
Edmond Marzbani
No relevant relationships to disclose